Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

ClinicalTrials.gov ID: NCT04184622

Public ClinicalTrials.gov record NCT04184622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 11:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weight. The study has two phases: A main phase and an extension phase. The main phase of the study will last 72 weeks. Participants with prediabetes will continue in the extension for another 2 years.

Study identification

NCT ID
NCT04184622
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
2,539 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2019 (Actual)
Primary completion
Apr 1, 2022 (Actual)
Completion
Jul 6, 2024 (Actual)
Last update posted
Jul 24, 2025

2019 – 2024

United States locations

U.S. sites
54
U.S. states
27
U.S. cities
50
Facility City State ZIP Site status
Cahaba Research Pelham Alabama 35124 —
Perseverance Research Center Scottsdale Arizona 85224 —
John Muir Physician Network Clinical Research Center Concord California 94520 —
Valley Research Fresno California 93720 —
National Research Institute - Wilshire Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
Encompass Clinical Research Spring Valley California 91978 —
University Clinical Investigators, Inc. Tustin California 92780 —
Yale University School of Medicine New Haven Connecticut 06519 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Suncoast Research Group Miami Florida 33135 —
New Horizon Research Center Miami Florida 33165 —
Renstar Medical Research Ocala Florida 34471 —
Oviedo Medical Research Oviedo Florida 32765 —
ForCare Clinical Research Tampa Florida 33613 —
Center for Advanced Research & Education Gainesville Georgia 30501 —
Herman Clinical Research Suwanee Georgia 30024 —
SKY Integrative Medical Center/SKYCRNG Union City Georgia 30291 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Midwest Institute for Clinical Research Indianapolis Indiana 46260 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Cotton O'Neil Diabetes & Endocrinology Topeka Kansas 66606 —
L-MARC Research Center Louisville Kentucky 40213 —
NECCR PrimaCare Research Fall River Massachusetts 02721 —
ActivMed Practices and Research Methuen Massachusetts 01844 —
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Clinvest Research LLC Springfield Missouri 65807 —
Palm Research Center Sunset Las Vegas Nevada 89148 —
Premier Research Trenton New Jersey 08611 —
NYU Langone Health New York New York 10016 —
Weill Cornell Medical College New York New York 10021 —
Rochester Clinical Research, LLC Rochester New York 14609 —
University of North Carolina Medical Center Chapel Hill North Carolina 27514 —
PharmQuest Greensboro North Carolina 27408 —
Lillestol Research Fargo North Dakota 58104 —
Velocity Clinical Research, Cleveland Cleveland Ohio 44122 —
Aventiv Research Inc Columbus Ohio 43213 —
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069 —
Summit Research Network Portland Oregon 97210 —
Detweiler Family Medicine & Associates Lansdale Pennsylvania 19446 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
Velocity Clinical Research, Providence East Greenwich Rhode Island 02818 —
Medical University of South Carolina Charleston South Carolina 29425 —
Mountain View Clinical Research, Inc. Greer South Carolina 29651 —
Coastal Carolina Research Center North Charleston South Carolina 29405 —
WR-Clinsearch, LLC Chattanooga Tennessee 37421 —
Texas Diabetes & Endocrinology, P.A. Austin Texas 78749 —
Dallas Diabetes Research Center Dallas Texas 75230 —
North Texas Endocrine Center Dallas Texas 75231 —
Research Institute of Dallas Dallas Texas 75231 —
Southern Endocrinology Associates Mesquite Texas 75149 —
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04184622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2025 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04184622 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →